Authors
Latest:
Leukemia: Causes, Symptoms, and TreatmentsLeukemia is a type of cancer that affects blood cell formation and the lymphatic system. It can be classified by cell type, lymphoid or myeloid, and the rate of progression, acute or chronic.
Latest:
New Evidence Concerning Safety of ACE Inhibitors, ARBs in COVID-19There continues to be a debate in the scientific community about the role that angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers play in coronavirus disease 2019 infection.
Latest:
Expert Panel Examines Biosimilar PathwayThe FDA does not usually require animalstudies for biosimilars; therefore, the process can move directly to pharmacokinetic and pharmacodynamic studies.
Latest:
Burden of Autosomal Dominant Polycystic Kidney Disease: Systematic Literature ReviewThe authors present a review of the literature for autosomal dominant polycystic kidney disease to characterize its impact on patients and healthcare systems.
Latest:
Factors Associated With Employee Participation in a Value-Based Insurance Design InitiativeWe describe enrollment in a voluntary VBID initiative. Uptake was suboptimal, suggesting that barriers to enrollment may have significant implications for the overall effectiveness of VBID.
Latest:
What Factors Influence Response to Multiple Myeloma Treatment?Two recent studies analyzed factors that impacted response to therapy in patients with multiple myeloma.
Latest:
To Substitute or Not to Substitute: That Is the QuestionWith generic prescriptions on the rise, every pharmacist needs a through understanding of therapeutic equivalence and the generic approval process.
Latest:
PLEI Perspectives: Flipping Your Idea of EducationThe pharmacy profession continues to expand its scope of practice, and some may argue that current PharmD curricula inadequately prepare students for this rapidly growing career.
Latest:
Get PrEPared for HIV ProphylaxisExpansion to adolescents, flexible dosing strategies, innovative delivery models, and long-acting antiretrovirals all help the strategy.
Latest:
Liposomal Bupivacaine as a Foundation for Multimodal Analgesia in the Postoperative SettingA 50-year-old male with a history of benign prostatic hyperplasia, chronic obstructive pulmonary disease, and type 2 diabetes mellitus is admitted for a laparoscopic colectomy. The patient's surgeon requests a pharmacy consultation to develop a multimodal, opioid-sparing pain control regimen.
Latest:
3 Tips for Launching a Peer Mentoring ProgramThe first days of pharmacy school can be exciting for students because they are embarking on a new chapter of their lives.
Latest:
Geriatric Cancers Present Many Therapeutic ChallengesPharmacists should develop treatment plans with an active interdisciplinary team and patient involvement.
Latest:
Pharmacists in ACOs Part 3: Chronic Care Management, Chronic Disease State Management, and Transition of CareAfter discussing the Basics of Accountable Care Organizations and Medication Therapy Management and Annual Wellness Visit services, the third and last section of the Pharmacists in ACOs series will focus on 3 more integration strategies for pharmacists within the ACO setting, including chronic care management, chronic disease state management, and transitions of care.
Latest:
Protein S DeficiencyProtein S deficiency is a type of inherited thrombophilia associated with increased risk of venous thromboembolism.
Latest:
Alpha-Gal (Mammalian Meat) Allergy: Implications for PharmacistsAlpha-gal, a mammalian oligosaccharide, has recently been implicated in delayed anaphylaxis reactions to mammalian meat.
Latest:
Second Look at Utilization of a Closed-System Transfer Device (PhaSeal)The Phaseal closed-system transfer device can extend the beyond-use date of pharmaceuticals, thereby reducing waste.
Latest:
caseSTUDIESLatest:
Head Lice Treatment: Perspective for PharmacistsAn estimated 6 to 12 million individuals in the United States develop head lice each year, with most cases occurring in children ages 3 to 11.
Latest:
Heart Failure: Implications for Quality Improvement and Hands-on TrainingThis Continuing Education activity is supported by an educational grant from Novartis Pharmaceuticals Corporation..
Latest:
Do Units and Costs of Comparable Insulins Differ by Manufacturer?Patient characteristics and product mix play an important role in determining the overall use and costs of comparable insulins across different manufacturers.
Latest:
CASE STUDIESLatest:
Summary of Current SARS-CoV-2 Vaccine TrialsMany clinical trials are underway in a race to develop a safe and effective vaccine against severe acute respiratory SARS-CoV-2, the virus that causes COVID-19.
Latest:
Improving the Patient Journey Through Health System Partnerships Enhances CareHealth system specialty pharmacies are creating a more integrated care structure for complex patients on specialty drug regimens.
Latest:
Diabetes Quality Measurement: A Primer for PharmacistsThe continuing education article reviews diabetes quality improvement efforts and the potential for expanding the role of pharmacists as clinical care providers.
Latest:
Is PBM Transparency an Answer to Controlling Rising Drug Costs?With continued increases in the US drug spend, the evolution of fully transparent PBM programs has introduced an alternative approach to traditional PBM structures aimed at enhanced utilization and cost control.
Latest:
Cost and Utilization Outcomes Associated With a Dosage Consolidation and Quantity Limits ProgramDose consolidation and quantity limit initiatives decreased utilization and cost outcomes for select mental health drugs in a fee-for-service Medicaid environment.
